<code id='F928570849'></code><style id='F928570849'></style>
    • <acronym id='F928570849'></acronym>
      <center id='F928570849'><center id='F928570849'><tfoot id='F928570849'></tfoot></center><abbr id='F928570849'><dir id='F928570849'><tfoot id='F928570849'></tfoot><noframes id='F928570849'>

    • <optgroup id='F928570849'><strike id='F928570849'><sup id='F928570849'></sup></strike><code id='F928570849'></code></optgroup>
        1. <b id='F928570849'><label id='F928570849'><select id='F928570849'><dt id='F928570849'><span id='F928570849'></span></dt></select></label></b><u id='F928570849'></u>
          <i id='F928570849'><strike id='F928570849'><tt id='F928570849'><pre id='F928570849'></pre></tt></strike></i>

          Home / fashion / comprehensive

          comprehensive


          comprehensive

          author:Wikipedia    Page View:2982
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In